Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
18655 Krause Street , Riverview, MI, 48193, US
Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO) offering end-to-end development and manufacturing solutions across the entire drug life cycle. Leveraging an integrated network of facilities in North America, Europe, and India, we provide a comprehensive range of drug discovery services, early phase active pharmaceutical ingredient (API) and formulation development services, and late phase and commercial API and formulation services. We also offer specialized solutions for highly potent APIs, antibody-drug conjugations, sterile fill/finish, peptides, potent solid oral drug products, vaccines, and biologics/bio-therapeutics.
Advances in payload-linker technology have made ADCs a major therapeutic modality, prompting drug developers to strive for greater selectivity and safety in the next wave of ADCs. Payload-linker selection is vital to these initiatives, making the choice of an experienced development and manufacturing partner a key decision in the highly competitive ADC market.
Released By Piramal Pharma Solutions
How Piramal Pharma is shaping resilient, patient-centric development across OSDs, HPAPIs, and sterile injectables.
From discovery to intermediates, APIs & drug products, a CDMO needs expertise across multiple elements of the pharma process to deliver an integrated experience
Site has produced hundreds of distinct bioconjugates and supports clinical, commercial, and non‑GMP manufacturing activities.
By: Charlie Sternberg
Enables more flexible and customizable dosing options for critical oral drug therapies, including modified release drug delivery.
The S&P Global CSA analyzes companies on environmental, social, and governance performance, governance maturity, and long-term value creation.
Underscores the facility’s dedication to upholding the highest standards of quality across operations.
Agreement expands Piramal’s payload-linker platform and bioconjugate abilities.
Provides the Morgpeth facility’s Formulation Development Team with an important tool for developing fixed dose combinations and modified release drug delivery.
The U.S. Food and Drug Administration (FDA) approved WIDAPLIK on June 6, 2025.
The investment provides NewAmsterdam Pharma with commercial capacity for a fixed-dose combination of obicetrapib and ezetimibe to meet potential commercial demand.
Dr. Max Lauwiner, CEO of Valsynthese, discusses the role of small-sized CDMOs in securing Pharma innovation pipelines.
Released By Valsynthese
Huang brings 25+ years of leadership experience across the pharmaceutical and CDMO sectors.
Why pragmatic, risk-based quality systems may offer a smarter path for sponsors and CDMOs than compliance theater and zero-defect thinking.
By: Lisa Cozza, Scott Myers
Delivers faster changeovers, higher OEE, and improved operational efficiency for pharmaceutical manufacturers and CDMO environments.
Elmalem will be responsible for site operations, and continue to oversee engineering activities.
By: Patrick Lavery
PPS to leverage its North American drug substance facilities to support patient access to Sofdra.
A newly formed subsidiary, Excellos Labs, will now be responsible for San Diego-based operations.
Enhances the company’s ability to support global payload-linker development and manufacturing at its Riverview, Michigan drug substance facility.
A closer look at how CDMOs safely handle volatile chemistry to transform isoprene into high-value specialty products.
McCullough Wood offers nearly three decades of experience across API, CDMO, and drug product services.
Rengis brings extensive international leadership experience across pharmaceutical manufacturing, R&D and CDMO operations.
Beyond streamlining routine workflows, emerging capabilities are shaping how organizations evaluate risk, prioritize investments, and plan for long-term growth.
By: Gregory Kline
Dr. Steinhagen brings more than 25 years of experience across pharma, biotech and the CRO/CDMO sector.
Creates an end-to-end CDMO platform for pharma and biotech.
Michelle D’Angelo brings 25+ years of experience in the pharmaceutical and biotechnology CDMO sector.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
